共 41 条
[1]
Llovet JM(1999)Natural history of untreated nonsurgical hepatocellular carcinoma: rationale for the design and evaluation of therapeutic trials Hepatology 29 62-67
[2]
Bustamante J(2012)EASL-EORTC clinical practice guidelines: management of hepatocellular carcinoma. European Association for the Study of the Liver; European Organisation for Research and Treatment of Cancer J Hepatol 56 908-943
[3]
Castells A(2005)The continuing challenge of hepatic cancer in Asia Surgeon. 3 210-215
[4]
Lai EC(2002)Locoregional therapies for hepatocellular carcinoma: a critical review from the surgeon’s perspective Ann Surg 235 466-486
[5]
Lau WY(2006)Treatment of hepatocellular carcinoma accompanied by portal vein tumor thrombus World J Gastroenterol 12 7561-7567
[6]
Poon RT(2011)A new classification for hepatocellular carcinoma with portal vein tumor thrombus J Hepatobil Pancreat Sci. 18 74-80
[7]
Fan ST(2012)Efficacy and safety of sorafenib in patients with advanced hepatocellular carcinoma: subanalyses of a phase III trial J Hepatol 57 821-829
[8]
Tsang FH(2019)Comprehensive treatments for hepatocellular carcinoma with portal vein tumor thrombosis J Cell Physiol 234 1062-1070
[9]
Minagawa M(2016)Multimodality treatment for hepatocellular carcinoma with portal vein tumor thrombus: a large-scale, multicenter, propensity mathching score analysis Medicine (Baltimore). 29 2992-2997
[10]
Makuuchi M(2012)Transarterial chemoembolization compared with conservative treatment for advanced hepatocellular carcinoma with portal vein tumor thrombus: using a new classification Med Oncol 6 139-148